Figure 2 | Scientific Reports

Figure 2

From: Metabolomics approach revealed robust changes in amino acid and biogenic amine signatures in patients with schizophrenia in the early course of the disease

Figure 2

Boxplots of the statistically significant variation of the errors (residuals) of log-transformed biomarker ratios (derived by regressing out covariate effects) for control subjects and first episode (FEP) patients at baseline (before treatment with antipsychotics (AP)), after 0.6-year, and after 5.1-year treatment with AP.

Back to article page